Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antigen distribution drives programmed antitumor CD8 cell migration and determines its efficiency.

Alexandre Boissonnas1, Christophe Combadiere, Elise Lavergne

  • 1Laboratoire d'Immunologie Cellulaire, Institut National de la Santé et de la Recherche Médicale, Unité 543, Faculté de Médecine Pitié-Salpêtrière, 91 Boulevard de l'Hôpital, 75634 Paris cedex 13, France.

Journal of Immunology (Baltimore, Md. : 1950)
|June 24, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epicardial Fat Drives Macrophage Response in Atrial Cardiomyopathy.

Circulation research·2026
Same author

The 1st Mediterranean Meeting on Flow Cytometry: Forging New Collaborations Across the Mediterranean and Beyond.

Cytometry. Part A : the journal of the International Society for Analytical Cytology·2026
Same author

Opposing Association of Lung Neutrophils and PD-L1<sup>+</sup> Monocytes in Age-Related Severity of SARS-CoV-2 Infection.

Aging cell·2026
Same author

Systems vaccinology analysis of saRNA immunization identifies an acute innate immune signature correlated with adaptive immunity.

Molecular therapy. Advances·2026
Same author

Impact of continuous local anesthetic wound infiltration on postoperative outcomes following open radical cystectomy: a comprehensive evaluation.

World journal of urology·2026
Same author

Establishing long-lasting vaccine immunity: insights from mRNA and adjuvanted protein platforms.

NPJ vaccines·2025

Initial antigen exposure programs CD8 T cells for tumor site migration. Continuous T cell receptor triggering is essential for CD8 T cell effector functions and survival during cancer therapy.

Area of Science:

  • Immunology
  • Cancer Biology
  • T cell Differentiation

Background:

  • Understanding CD8 T cell differentiation and dysfunction is critical for effective cancer immunotherapy.
  • Tumor antigens (Ag) and their distribution influence CD8 T cell responses.
  • Inefficient CD8 T cell function can limit therapeutic outcomes.

Purpose of the Study:

  • To investigate the in vivo CD8 T cell response to tumor antigens.
  • To determine the role of initial antigen encounter in CD8 T cell programming.
  • To elucidate the factors influencing CD8 T cell migration, effector function, and survival.

Main Methods:

  • Utilized a murine model with OT-1 CD8 T cells and EG-7 thymoma expressing ovalbumin (OVA).
  • Studied CD8 T cell responses in vivo following differential antigen distribution.

Related Experiment Videos

  • Analyzed T cell expansion, migration, chemokine receptor expression, CD62L levels, effector functions, and apoptosis.

    • Main Results:

    • Initial antigen encounter in lymph nodes induced programmed expansion and migration of OT-1 CD8 T cells to the tumor site after at least four divisions, without continuous stimulation.
    • Short antigenic stimulation initiated a migration differentiation program, including altered chemokine receptor mRNA expression and CD62L downregulation.
    • Antigen quantity modulated OT-1 CD8 T cell behavior, including effector functions and apoptosis sensitivity.

    Conclusions:

    • Initial antigen exposure is sufficient to program CD8 T cells for migration to tumor sites.
    • Continuous T cell receptor (TCR) triggering is necessary for CD8 T cell effector functions and survival (preventing apoptosis).
    • Antigen dose plays a key role in dictating CD8 T cell behavior and therapeutic potential.